CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-13 | MENDLEIN JOHN Director | Purchase | +36,631 | $5.43 | $199K | 282,770 |
| 2023-01-12 | Valamehr Bahram Chief R&D Officer | Option exercise | +423 | $1.37 | $580 | 169,340 |
| 2023-01-12 | Valamehr Bahram Chief R&D Officer | Option exercise · Stock Option (Right to Buy) | +423 | 0 | ||
| 2023-01-11 | MENDLEIN JOHN Director | Purchase | +88,048 | $5.67 | $499K | 246,139 |
Page 8 of 8 · 144 trades